Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis: outcome and economic analysis of the GERSHWIN study

被引：0
|
作者：
Willich, S. N.
Brueggenjuergen, B.
Mcbride, D.
Bode, C.
Hamm, C. W.
Kuck, K. -H.
机构：
[1] Charite Univ Med Berlin, Med Ctr, Inst Sozialmed & Epidemiol, Berlin, Germany
[2] Univ Hosp Freiburg, Freiburg, Germany
[3] Kerckhoff Klin, Bad Nauheim, Germany
[4] Ctr Heart, LBK, Hamburg, Germany
来源：
EUROPEAN HEART JOURNAL | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：769 / 769
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of sirolimus-eluting stents versus bare-metal stents in coronary artery disease patients with diabetes: a meta-analysis
    Qiao, Yanxiang
    Bian, Yuan
    Yan, Xianliang
    Liu, Zhenfang
    Chen, Yuguo
    CARDIOVASCULAR JOURNAL OF AFRICA, 2013, 24 (07) : 274 - 279
  • [22] Outcomes of Overlapping Bare-Metal Stents with Sirolimus-Eluting Stents for Long Lesions in Small Coronary Vessels
    Kronsteiner, Emily
    Lee, Richard W.
    Sweeney, John P.
    Metallo, Jennifer R.
    Stoehr, James D.
    Fortuin, F. David
    JOURNAL OF INVASIVE CARDIOLOGY, 2010, 22 (02): : 76 - 79
  • [23] COMPARISON OF THE CLINICAL AND ECONOMIC EFFECTIVENESS OF SIROLIMUS-ELUTING VERSUS BARE-METAL STENTS IN A SUBGROUP OF PATIENTS WITH AND WITHOUT DIABETES
    Brueggenjuergen, B.
    McBridge, D.
    Roll, S.
    Willich, S. N.
    VALUE IN HEALTH, 2008, 11 (06) : A381 - A382
  • [24] Clinical and Angiographic Outcomes Following Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Bare-Metal Stents in Hemodialysis Patients
    Yachi, Sen
    Tanabe, Kengo
    Tanimoto, Shuzou
    Aoki, Jiro
    Nakazawa, Gaku
    Yamamoto, Hirosada
    Otsuki, Shuji
    Yagishita, Atsuhiko
    Kishi, Satoru
    Nakano, Masataka
    Taniwaki, Masahiro
    Sasaki, Shunsuke
    Nakajima, Hiroyoshi
    Mise, Naofumi
    Sugimoto, Tokuichiro
    Hara, Kazuhiro
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (02) : 299 - 306
  • [25] Drug-Eluting Versus Bare-Metal Stents for Bare-Metal In-Stent Restenosis
    Singh, Inder M.
    Filbly, Steven J.
    El Sakr, Fredy
    Gorodeski, Eiran Z.
    Lincoff, A. Michael
    Ellis, Stephen G.
    Shishehbor, Mehdi H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 145D - 145D
  • [26] Drug-Eluting Stents Versus Bare-Metal Stents for Treatment of Bare-Metal In-Stent Restenosis
    Singh, Inder M.
    Filby, Steven J.
    El Sakr, Fredy
    Gorodeski, Eiran Z.
    Lincoff, A. Michael
    Ellis, Stephen G.
    Shishehbor, Mehdi H.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010, 76 (02) : 257 - 262
  • [27] Outcomes of bare-metal stents implanted simultaneously with sirolimus-eluting stents (Cypher) in multivessel coronary artery disease patients: Evaluation of systemic effects of sirolimus-eluting stents
    Kang, TS
    Yoon, YW
    Hong, BK
    Kwon, HM
    Cho, SY
    Kim, HS
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (8A): : 42A - 42A
  • [28] Drug-eluting versus bare-metal coronary stents:: 6-month clinical and economic outcomes of a controlled study for the reduction of coronary restenosis
    Brüggenjürgen, BH
    McBride, D
    Willich, SN
    VALUE IN HEALTH, 2005, 8 (03) : 337 - 338
  • [29] Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents
    Mauri, L
    O'Malley, AJ
    Popma, JJ
    Moses, JW
    Leon, MB
    Holmes, DR
    Teirstein, PS
    Cutlip, DE
    Donahoe, D
    Kuntz, RE
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (10): : 1140 - 1145
  • [30] Prospective, Randomized Trial of Paclitaxel-versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents
    Franke, J.
    HERZ, 2009, 34 (08) : 648 - 648
12345